XTENT INC 4
4 · XTENT INC · Filed Jan 3, 2008
Insider Transaction Report
Form 4
XTENT INCXTNT
Marco Philippe H
VP Quality Assurance, Clinical
Transactions
- Sale
Common Stock
2008-01-02$9.76/sh−400$3,904→ 109,150 total - Sale
Common Stock
2008-01-03$9.12/sh−475$4,332→ 106,975 total - Sale
Common Stock
2008-01-02$9.60/sh−100$960→ 109,950 total - Sale
Common Stock
2008-01-02$9.84/sh−200$1,968→ 108,550 total - Sale
Common Stock
2008-01-03$9.05/sh−100$905→ 107,850 total - Sale
Common Stock
2008-01-03$9.13/sh−200$1,826→ 106,775 total - Sale
Common Stock
2008-01-03$9.14/sh−125$1,143→ 106,650 total
Footnotes (1)
- [F1]Sale pursuant to rule 10b5-1(c) under the Securities and Exchange Act of 1934, as amended